Purchase Order W81K0016P0255
Award Date
6/1/16
Potential Completion Date
5/31/17
Potential Value
$99K
Federal Agency
Medical Command
Awardee
Meridian Bioscience Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cincinnati, OH 45244, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments. The contract, valued at $274,884.11, is for the supply of "PREMIER PLATINUM HPSA PLUS KITS" with a completion date of September 30, 2021. The contract is a firm fixed-price arrangement. Meridian Bioscience Inc. is a key supplier of diagnostic solutions to...
This is a firm-fixed-price Blanket Purchase Agreement (BPA) call order awarded by the U.S. Department of the Air Force Materiel Command to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic substances, reagents, test kits, and sets. The $167,063 contract provides clinical diagnostic products and supplies to support federal health and screening programs. Meridian Bioscience has previously delivered COVID-19 tests, lead testing systems, hepatitis assays,...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of the Air Force Materiel Command to Meridian Bioscience Inc., a foreign-owned for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments. The $154,150.00 contract is for the delivery of in vitro diagnostic substances, reagents, test kits, and sets, with a period of performance ending on September 30, 2018. There was no set-aside designation used for this award. Meridian Bioscience...
This is a firm-fixed-price purchase order contract awarded by the Veterans Integrated Service Network 22 (VISN 22) of the U.S. Department of Veterans Affairs to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments. The contract, valued at $19,000.00, is for the delivery of a breath urea analyzer with a period of performance ending on September 4, 2025. The contract was awarded on September 9, 2024 and does not have a...
This is a Firm Fixed Price delivery order awarded by the Defense Contract Management Agency to OEM Concepts Incorporated, a subsidiary of Meridian Bioscience Inc., a for-profit foreign-owned manufacturer of in vitro diagnostic test kits, reagents, and instruments. The $225,441.00 contract is for the purification of polyclonal antibodies, with a completion date of January 25, 2024. The contract has no set-aside designation. Meridian Bioscience has previously served as a prime contractor on...
This is a Blanket Purchase Agreement (BPA) call issued by the Veterans Integrated Service Network 22 (VISN 22) of the U.S. Department of Veterans Affairs (VA) to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits, reagents, and diagnostic instruments. The contract is for the procurement of I-STAT blood analyzers, with a ceiling value of $16,344.00 and a firm fixed price. The contract has a period of performance ending on June 24, 2026. Meridian...
This is a firm-fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at $16,879.50, is for the provision of Biomerieux's proprietary diagnostic platforms, reagents, and test kits to support the agency's infectious disease testing and pathogen detection requirements. The contract does not have a set-aside designation, as Biomerieux is often the sole source provider for its specialized...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Meridian Bioscience Inc., a manufacturer of in vitro diagnostic test kits, reagents, and instruments for the Tripler Army Medical Center in Hawaii. The contract, which has no set-aside designation, is for the delivery of Meridian reagents required for various clinical testing and screening applications at the medical center, including for varicella zoster virus, mycoplasma, rotavirus, mononucleosis, ova and...
This is a Blanket Purchase Agreement (BPA) call awarded by the Indian Health Service (IHS), a civilian agency, to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits and medical equipment. The BPA call, valued at $181,425.00, is for the procurement of laboratory supplies and an extended warranty for the Meridian Bioscience BREATH ID Smart System. The contract does not have a set-aside designation and has a period of performance through June 16,...
The U.S. government has awarded a Firm Fixed Price Delivery Order contract to Biomerieux Inc., a global leader in in vitro diagnostics, for the supply of BioMerieux STEC kits during the period of January to March 2025. The contract, valued at $84,675.00, was issued by the Office of Administrative Services Procurement Management Branch, a civilian agency. The contract does not have a set-aside designation. Biomerieux Inc., through its Biomerieux, Inc. Division, is the prime contractor and has...